Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome

Akpek, G.; Bunjes, D. W.; Copelan, E. A.; De Lima, M.; Devine, S. M.; Freytes, C.; Gale, R. P.; Goyal, S. D.; Hamadani, M.; Inamoto, Y.; Kamble, R. T.; Lazarus, H. M.; Marks, D. I.; Nishihori, T.; Olsson, R. F.; Reshef, R.; Ritchie, D. S.; Saber, W.; Savani, B. N.; Seber, A.; Shea, T. C.; Tallman, M. S.; Uy, G. L.; Wang, H. L.; Weisdorf, D. J.; Wirk, B.; Zhang, M. J.

Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome

Authors: G. Akpek
D. W. Bunjes
E. A. Copelan
M. De Lima
S. M. Devine
C. Freytes
R. P. Gale
S. D. Goyal
M. Hamadani
Y. Inamoto
R. T. Kamble
H. M. Lazarus
D. I. Marks
T. Nishihori
R. F. Olsson
R. Reshef
D. S. Ritchie
W. Saber
B. N. Savani
A. Seber
T. C. Shea
M. S. Tallman
G. L. Uy
H. L. Wang
D. J. Weisdorf
B. Wirk
M. J. Zhang
Publication date: 1 January 2015
Publisher
Doi

Abstract

The impact of extramedullary disease (EMD) in AML on the outcomes of allogeneic hematopoietic cell transplantation (alloHCT) is unknown. Using data from the Center for International Blood and Marro ..

Similar works

Full text

Open in the Core reader

Download PDF

Available Versions

Carolina Digital Repository

cdr.lib.unc.edu:0g354n12c

Last time updated on 24/11/2020

University of Melbourne Institutional Repository

oai:jupiter.its.unimelb.edu.au...

Last time updated on 29/04/2021